Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Vopr Onkol ; 52(2): 196-9, 2006.
Article in Russian | MEDLINE | ID: mdl-17195648

ABSTRACT

Data on the treatment of 215 patients with locally advanced malignancies of the nasal cavity and accessory nasal sinus are presented. All patients received preoperative radiotherapy using different fractionation schemes under a total target dose (TTD) of 32-40 Gy. Surgery was carried out two weeks later. Whenever radicality of surgery was in doubt, postoperative gamma therapy included exposure to 2 Gy 5 times a week (TTD--30-40 Gy) (n=121). Group I (n-57) received radiation at standard fractionated dosage. In group II (n=66), fractionation, tentatively considered "dynamic" was used while, in group III, fractionation was dynamic in actual fact. In group IV (n=10), superfractionation (1+1 Gy) was employed in group V (n=6),--gamma-neutron therapy. Patients in group VI (n=51) were operated on as scheduled and received 5 Gy, twice a week (TTD--20 Gy). According to 5-year follow-up, the best results were obtained with the use of larger doses of preoperative radiation (groups II, III, VI). Postoperative radiotherapy proved ineffective and it would be useless unless ablative procedures were definitely faulty during surgery.


Subject(s)
Dose Fractionation, Radiation , Neoadjuvant Therapy/methods , Nose Neoplasms/therapy , Adult , Aged , Female , Follow-Up Studies , Gamma Rays , Humans , Male , Middle Aged , Nose Neoplasms/radiotherapy , Nose Neoplasms/surgery , Paranasal Sinus Neoplasms/therapy , Radiotherapy, Adjuvant , Treatment Failure , Treatment Outcome
2.
Vopr Onkol ; 52(2): 200-2, 2006.
Article in Russian | MEDLINE | ID: mdl-17195649

ABSTRACT

The study deals with the results of examination and treatment of 1040 patients with cancer (T3-4N0-3M0) of larynx and laryngopharynx. Radiotherapy was given to 358 patients concurrently with systemic polychemotherapy and different means of radiomodification. The remaining patients (682) receiving the same treatment minus systemic polychemotherapy were in control. Relapse-free (72.6%) and overall survival (82.7%) in the study group was significantly higher than in controls (54.7% and 63.4%, respectively) (p < 0.001). Moreover, an organ's function was preserved in 57.1% compared with 28.5% in control (p < 0.001).


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Laryngeal Neoplasms/drug therapy , Laryngeal Neoplasms/radiotherapy , Pharyngeal Neoplasms/drug therapy , Pharyngeal Neoplasms/radiotherapy , Radiotherapy, Adjuvant/methods , Adult , Aged , Chemotherapy, Adjuvant , Disease-Free Survival , Female , Humans , Laryngeal Neoplasms/pathology , Laryngeal Neoplasms/physiopathology , Male , Middle Aged , Pharyngeal Neoplasms/physiopathology , Pharyngeal Neoplasms/secondary , Quality of Life , Survival Analysis , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...